Professional Media briefs

Share this article:
A review of 202 articles on the risk of heart attacks with rosiglitazone (Avandia) concluded that authors who had a favorable view of the risk of heart attack with the drug were more likely to have conflicts of interest with manufacturers of antihyperglycemic agents in general and Avandia maker GlaxoSmithKline. The study, published in the British Medical Journal, found that just over half of the articles had a conflict of interest statement and 45% of authors had a financial relationship with a manufacturer.

Members of the International Committee of Medical Journal Editors met for the first time in Queenstown, New Zealand last month. Topics of discussion at the two-day meeting included conflict of interest worries and pharma financial relationships with physicians.  

Monthly Prescribing Reference is celebrating its 25th anniversary in June. The brand is owned by MM&M parent Haymarket.

The American Medical Association plans to freshen up the Disaster Medicine and Public Health Preparedness Journal. “A more sophisticated platform is being developed to help improve the journal's visibility and engagement with the medical and public health community,” said the AMA.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.